Literature DB >> 20978182

Priorities for endometriosis research: a proposed focus on deep dyspareunia.

Paolo Vercellini1, Marta Meana, Lone Hummelshoj, Edgardo Somigliana, Paola Viganò, Luigi Fedele.   

Abstract

Women with endometriosis have a substantial increase in risk of deep dyspareunia with respect to the general female population of corresponding age. This symptom has personal and intimate implications, including unfavorable emotional impact in partners. Deep dyspareunia caused by endometriosis can be viewed as an originally visceral type of pain secondary to chronic inflammation (nociception) but with several superimposed components, including hyperalgesia, abnormal cortical perception, and psychological factors. Therefore, a simplistic biometric approach does not allow a comprehensive and elaborated assessment of the global impact of the symptom on women's sexual function, psychological well-being, body-image, self-esteem, and relational adjustment. We suggest 10 specific issues to be addressed in future research on a clinically as well as scientifically neglected aspect of female health. Time has come to address this physically and psychologically distressing affliction without embarrassment and with a decidedly multidisciplinary perspective.

Entities:  

Mesh:

Year:  2010        PMID: 20978182     DOI: 10.1177/1933719110382921

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  10 in total

1.  Carbon dioxide (CO2) laser ablation of symptomatic vaginal endometriosis: a pilot study.

Authors:  Laura Buggio; Ermelinda Monti; Carlo Liverani; Maria Pina Frattaruolo; Dhouha Dridi; Edgardo Somigliana
Journal:  Lasers Med Sci       Date:  2020-10-16       Impact factor: 3.161

Review 2.  A systematic review on the effects of endometriosis on sexuality and couple's relationship.

Authors:  P Norinho; M M Martins; H Ferreira
Journal:  Facts Views Vis Obgyn       Date:  2020-10-08

3.  Pain and endometriosis: Etiology, impact, and therapeutics.

Authors:  Robert N Taylor; Lone Hummelshoj; Pamela Stratton; Paolo Vercellini
Journal:  Middle East Fertil Soc J       Date:  2012-12-01

4.  Anatomic Sites and Associated Clinical Factors for Deep Dyspareunia.

Authors:  Paul J Yong; Christina Williams; Ali Yosef; Fontayne Wong; Mohamed A Bedaiwy; Sarka Lisonkova; Catherine Allaire
Journal:  Sex Med       Date:  2017-08-01       Impact factor: 2.491

5.  Patient-Physician Interactions Regarding Dyspareunia with Endometriosis: Online Survey Results.

Authors:  Kathryn Witzeman; Oscar Antunez Flores; Roberta I Renzelli-Cain; Brett Worly; Janelle K Moulder; Jorge F Carrillo; Beth Schneider
Journal:  J Pain Res       Date:  2020-06-29       Impact factor: 3.133

6.  Endometriosis and Sexual Quality of Life.

Authors:  Mikal van Poll; Esther van Barneveld; Luca Aerts; Jacques W M Maas; Arianne C Lim; Bianca T A de Greef; Marlies Y Bongers; Nehalennia van Hanegem
Journal:  Sex Med       Date:  2020-07-22       Impact factor: 2.491

Review 7.  The Subjective Experience of Dyspareunia in Women with Endometriosis: A Systematic Review with Narrative Synthesis of Qualitative Research.

Authors:  Federica Facchin; Laura Buggio; Dhouha Dridi; Giussy Barbara; Paolo Vercellini
Journal:  Int J Environ Res Public Health       Date:  2021-11-18       Impact factor: 3.390

8.  Reductions in endometriosis-associated pain among women treated with elagolix are consistent across a range of baseline characteristics reflective of real-world patients.

Authors:  Mauricio S Abrao; Eric Surrey; Keith Gordon; Michael C Snabes; Hui Wang; Horia Ijacu; Hugh S Taylor
Journal:  BMC Womens Health       Date:  2021-06-16       Impact factor: 2.809

Review 9.  Endometriosis, angiogenesis and tissue factor.

Authors:  Graciela Krikun
Journal:  Scientifica (Cairo)       Date:  2012-07-11

10.  Impact of endometriosis on women's lives: a qualitative study.

Authors:  Maryam Moradi; Melissa Parker; Anne Sneddon; Violeta Lopez; David Ellwood
Journal:  BMC Womens Health       Date:  2014-10-04       Impact factor: 2.809

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.